Charles Schwab Investment Management Inc Green Light Biosciences Holdings, Pbc Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.18 - $0.48 $42,400 - $113,068	-235,559 Reduced 39.11%	366,666 $109,000
Q1 2023 May 11, 2023	SELL	$0.34 - $1.19 $2,239 - $7,839	-6,588 Reduced 1.08%	602,225 $258,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.0 $134,066 - $260,324	130,162 Added 27.19%	608,813 $718,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $64,693 - $603,801	154,031 Added 47.45%	478,651 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	N/A	20,933 Added 6.89%	324,620 $718,000

Q1 2022 May 13, 2022	BUY	N/A	303,687 New	303,687 $2.93 Million

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.